abstract |
The present invention relates to: an L1 mutant peptide; a composition for alleviating, inhibiting, preventing or treating myopathy, obesity or diabetes, containing same as an active gradient; a method for alleviating, inhibiting, preventing or treating myopathy, obesity or diabetes by using the L1 mutant peptide; and a use, of the L1 mutant peptide, for alleviating, inhibiting, preventing or treating myopathy, obesity or diabetes. |